Joaquim Ferreira

引用先

	すべて	2020 年以来
引用	27351	13779
h 指標	82	57
i10 指標	336	265

2900

1450

725

2175

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202589 105 123 199 281 321 318 449 487 597 619 733 825 991 1406 1671 1779 1833 2240 2721 2870 2657 2863 377

オープンアクセス

すべて表示

164 件の論文

23 件の論文

利用可能

利用不可

助成機関の要件に基づく

共著者

Olivier RASCOLUT3 Professor, CHU Purpan, Tonic (INSERM-UT3), CIC 1436 (INSERM-CHU-UT3), TMBI (Univ. Toulouse)確認したメールアドレス: univ-tlse3.fr
João CostaFaculdade de Medicina da Universidade de Lisboa確認したメールアドレス: medicina.ulisboa.pt
Werner PoeweProfessor Neurologie確認したメールアドレス: i-med.ac.at
Angelo AntoniniUniversity of Padua確認したメールアドレス: unipd.it
Fausto PintoProfessor of Cardiology, Lisbon University Medical School確認したメールアドレス: medicina.ulisboa.pt
Filipe Brogueira RodriguesMedical Director, Medpace確認したメールアドレス: medpace.com
Gonçalo S DuarteLaboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina, Universidade de Lisboa確認したメールアドレス: edu.ulisboa.pt
Raquel Bouça-MachadoInvestigator, Lisbon Faculty of Medicine確認したメールアドレス: campus.ul.pt
Bastiaan R. BloemProfessor of movement disorders neurology, Radboudumc, Nijmegen, the Netherlands確認したメールアドレス: radboudumc.nl
Anette SchragUniversity College London確認したメールアドレス: doctors.org.uk
Anthony E LangUniversity of Toronto確認したメールアドレス: uhnres.utoronto.ca
Tiago Fleming OuteiroUniversity Medical Center Goettingen, Goettingen, Germany確認したメールアドレス: gwdg.de
Ricardo M FernandesFaculty of Medicine, University of Lisbon確認したメールアドレス: campus.ul.pt
Kailash BhatiaProfessor of Clinical Neurology, Institute of Neurology, UCL, Queen Square, London WC1N 3BG,確認したメールアドレス: ucl.ac.uk
Alexandre Castro CaldasCentro de Investigação Interdisciplinar em Saúde - Instituto de Ciências da Saúde - Universidade確認したメールアドレス: ics.lisboa.ucp.pt
christine Brefel-courbonMCU PH, Neuropharmacologie, CHU Toulouse; TONIC (INSERM UT3); TMBI Univ Toulouse確認したメールアドレス: univ-tlse3.fr
Cláudio DavidMedicina Lisboa確認したメールアドレス: campus.ul.pt
Günther DeuschlDepartment of Neurology, UKSH, Christian-Albrechts University Kiel確認したメールアドレス: neurologie.uni-kiel.de
Carlo ColosimoSanta Maria University Hospital, Terni, Italy確認したメールアドレス: uniroma1.it
Rita G. NunesInstitute for Systems and Robotics (ISR/IST), LARSyS, Instituto Superior Técnico, Universidade de確認したメールアドレス: tecnico.ulisboa.pt

フォロー

Joaquim Ferreira

Faculdade de Medicina, Universidade de Lisboa

確認したメールアドレス: medicina.ulisboa.pt - ホームページ

Parkinson's disease Huntington Systematic Review Movement Disorders Neurology


タイトル引用回数順公開年順タイトル順	引用先引用先	年
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study DG Healy, M Falchi, SS O'Sullivan, V Bonifati, A Durr, S Bressman, ... The Lancet Neurology 7 (7), 583-590, 2008	1749	2008
How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor ED Louis, JJ Ferreira Movement Disorders 25 (5), 534-541, 2010	1107	2010
Corticosteroids for Bell's palsy (idiopathic facial paralysis) VB Madhok, I Gagyor, F Daly, D Somasundara, M Sullivan, F Gammie, ... Cochrane database of systematic reviews, 2016	838	2016
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease A Di Fonzo, CF Rohé, J Ferreira, HF Chien, L Vacca, F Stocchi, L Guedes, ... The Lancet 365 (9457), 412-415, 2005	689	2005
EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease A Berardelli, GK Wenning, A Antonini, D Berg, BR Bloem, V Bonifati, ... European journal of neurology 20 (1), 16-34, 2013	668	2013
Summary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of P arkinson's disease JJ Ferreira, R Katzenschlager, BR Bloem, U Bonuccelli, D Burn, ... European journal of neurology 20 (1), 5-15, 2013	589	2013
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease A Di Fonzo, HF Chien, M Socal, S Giraudo, C Tassorelli, G Iliceto, ... Neurology 68 (19), 1557-1562, 2007	463	2007
Limitations of current Parkinson's disease therapy O Rascol, P Payoux, F Ory, JJ Ferreira, C Brefel‐Courbon, JL Montastruc Annals of Neurology: Official Journal of the American Neurological …, 2003	434	2003
Quantitative wearable sensors for objective assessment of Parkinson's disease W Maetzler, J Domingos, K Srulijes, JJ Ferreira, BR Bloem Movement Disorders 28 (12), 1628-1637, 2013	408	2013
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ... The Lancet Neurology 16 (9), 701-711, 2017	332	2017
Dopamine agonist therapy in early Parkinson's disease R Stowe, N Ives, CE Clarke, J Ferreira, RJ Hawker, L Shah, K Wheatley, ... Cochrane Database of Systematic Reviews, 2008	323	2008
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease M Martins, A Rosa, LC Guedes, BV Fonseca, K Gotovac, S Violante, ... PloS one 6 (10), e25443, 2011	309	2011
Scales to assess sleep impairment in Parkinson's disease: critique and recommendations B Högl, I Arnulf, C Comella, J Ferreira, A Iranzo, B Tilley, C Trenkwalder, ... Movement Disorders 25 (16), 2704-2716, 2010	299	2010
Late-stage Parkinson disease M Coelho, JJ Ferreira Nature Reviews Neurology 8 (8), 435-442, 2012	297	2012
Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial JJ Ferreira, A Lees, JF Rocha, W Poewe, O Rascol, P Soares-da-Silva The Lancet Neurology 15 (2), 154-165, 2016	282	2016
DYSBOT: a single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin … C Sampaio, JJ Ferreira, F Simões, MJ Rosas, M Magalhães, AP Correia, ... Movement disorders 12 (6), 1013-1018, 1997	271	1997
A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson’s disease C Godinho, J Domingos, G Cunha, AT Santos, RM Fernandes, D Abreu, ... Journal of neuroengineering and rehabilitation 13, 1-10, 2016	270	2016
Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis FB Rodrigues, JB Neves, D Caldeira, JM Ferro, JJ Ferreira, J Costa bmj 353, 2016	266	2016
Botulinum toxin type A therapy for blepharospasm J Costa, CC Espírito‐Santo, AA Borges, J Ferreira, MM Coelho, P Moore, ... Cochrane Database of Systematic Reviews, 2004	257*	2004
Sleep attacks and Parkinson's disease treatment JJ Ferreira, M Galitzky, JL Montastruc, O Rascol The Lancet 355 (9212), 1333-1334, 2000	252	2000

現在システムで処理を実行できません。しばらくしてからもう一度お試しください。

論文 1–20

年間引用数

重複した引用

結合された引用

共著者を追加共著者

フォロー

引用先

共著者